A vomiting-free ward protocol significantly reduced the effects of nausea and vomiting on QOL, anxiety, and depression, in patients with gynecologic cancers receiving chemotherapy.

Researchers conducted a population-based study to assess trends in thyroid cancer diagnoses in the US since 1975.

Our data clearly show that it is feasible and safe to implement stepwise acceleration of nivolumab and pembrolizumab administration to a 10-minute infusion time,” the researchers wrote.

Twelve months after revaccination, antibody levels declined but remained significantly higher than baseline in patients with CLL.

CRC cases exceeded expected numbers in patients with late-stage disease and in those aged younger than 50 years, 76 years or older.

Prevalence of dyspnea is high among advanced cancer survivors, with several associated factors, stressing a need for early detection and comprehensive management strategies.

Researchers compared outcomes associated with conventional excision vs Mohs micrographic surgery among patients with hand and foot melanoma.

Two major contributors to reduced health-related quality of life (HRQoL) in patients with chronic lymphocytic leukemia (CLL) and lymphoma are muscle weakness and fatigue, according to a study ...

The researchers called for further study to understand the mechanism of the relationship between obesity and ICI outcomes.

The findings suggest that enfortumab vedotin, especially combined with pembrolizumab, offers promising beneficial outcomes in metastatic urothelial carcinoma treatment,” researchers wrote.

Patients with initial nodal metastases and breast pCR on vacuum-assisted biopsy who underwent targeted axillary dissection had axillary pCR.

Luveltamab tazevibulin demonstrated activity in an ongoing phase 2/3 trial of patients with FRα-positive, platinum-resistant ovarian cancer.